Metropolis Healthcare to acquire 51% stake in Shraddha Diagnostic Centre

16 Jan 2020 Evaluate

Metropolis Healthcare has executed Share Purchase and Shareholders' Agreement for the acquisition of 51% shareholding in Shraddha Diagnostic Centre (I). The purpose of the acquisition is to strengthen the presence of the company in the state of Gujarat, India.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

2131.90 -42.70 (-1.96%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7236.35
Max Healthcare Inst 1193.20
Narayana Hrudayalay 1280.95
Aster DM Healthcare 494.95
Global Health 1133.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.